Literature DB >> 18456659

TAB4 stimulates TAK1-TAB1 phosphorylation and binds polyubiquitin to direct signaling to NF-kappaB.

Todd D Prickett1, Jun Ninomiya-Tsuji, Peter Broglie, Tara L Muratore-Schroeder, Jeffrey Shabanowitz, Donald F Hunt, David L Brautigan.   

Abstract

Responses to transforming growth factor beta and multiple cytokines involve activation of transforming growth factor beta-activated kinase-1 (TAK1) kinase, which activates kinases IkappaB kinase (IKK) and MKK3/6, leading to the parallel activation of NF-kappaB and p38 MAPK. Activation of TAK1 by autophosphorylation is known to involve three different TAK1-binding proteins (TABs). Here we report a protein phosphatase subunit known as type 2A phosphatase-interacting protein (TIP) that also acts as a TAB because it co-precipitates with and directly binds to TAK1, enhances TAK1 autophosphorylation at unique sites, and promotes TAK1 phosphorylation of IKKbeta and signaling to NF-kappaB. Mass spectrometry demonstrated that co-expression of TAB4 protein significantly increased phosphorylation of four sites in TAK1, in a linker region between the kinase and TAB2/3 binding domains, and two sites in TAB1. Recombinant GST-TAB4 bound in an overlay assay directly to inactive TAK1 and activated TAK1 but not TAK1 phosphorylated in the linker sites, suggesting a bind and release mechanism. In kinase assays using TAK1 immune complexes, added GST-TAB4 selectively stimulated IKK phosphorylation. TAB4 co-precipitated polyubiquitinated proteins dependent on a Phe-Pro motif that was required to enhance phosphorylation of TAK1. TAB4 mutated at Phe-Pro dominantly interfered with IL-1beta activation of NF-kappaB involving IKK-dependent but not p38 MAPK-dependent signaling. The results show that TAB4 binds TAK1 and polyubiquitin chains to promote specific sites of phosphorylation in TAK1-TAB1, which activates IKK signaling to NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456659      PMCID: PMC2443674          DOI: 10.1074/jbc.M800943200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  The role of phosphatases in TOR signaling in yeast.

Authors:  K Düvel; J R Broach
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

2.  TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains.

Authors:  Atsuhiro Kanayama; Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Mei Hong; Abdullah Shaito; Yu-Hsin Chiu; Li Deng; Zhijian J Chen
Journal:  Mol Cell       Date:  2004-08-27       Impact factor: 17.970

3.  TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism.

Authors:  H Sakurai; N Shigemori; K Hasegawa; T Sugita
Journal:  Biochem Biophys Res Commun       Date:  1998-02-13       Impact factor: 3.575

Review 4.  Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.

Authors:  Michael U Martin; Holger Wesche
Journal:  Biochim Biophys Acta       Date:  2002-11-11

5.  Identification of a PP2A-interacting protein that functions as a negative regulator of phosphatase activity in the ATM/ATR signaling pathway.

Authors:  J L McConnell; R J Gomez; L R A McCorvey; B K Law; B E Wadzinski
Journal:  Oncogene       Date:  2007-03-26       Impact factor: 9.867

6.  Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases.

Authors:  C J Di Como; K T Arndt
Journal:  Genes Dev       Date:  1996-08-01       Impact factor: 11.361

7.  The PP2A-associated protein alpha4 is an essential inhibitor of apoptosis.

Authors:  Mei Kong; Casey J Fox; James Mu; Laura Solt; Anne Xu; Ryan M Cinalli; Morris J Birnbaum; Tullia Lindsten; Craig B Thompson
Journal:  Science       Date:  2004-10-22       Impact factor: 47.728

8.  TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase.

Authors:  K Shirakabe; K Yamaguchi; H Shibuya; K Irie; S Matsuda; T Moriguchi; Y Gotoh; K Matsumoto; E Nishida
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

9.  TAB3, a new binding partner of the protein kinase TAK1.

Authors:  Peter C F Cheung; Angel R Nebreda; Philip Cohen
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

10.  TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction.

Authors:  H Shibuya; K Yamaguchi; K Shirakabe; A Tonegawa; Y Gotoh; N Ueno; K Irie; E Nishida; K Matsumoto
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

View more
  27 in total

1.  Autoactivation of transforming growth factor beta-activated kinase 1 is a sequential bimolecular process.

Authors:  Roland Scholz; Corinne L Sidler; Ramon F Thali; Nicolas Winssinger; Peter C F Cheung; Dietbert Neumann
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Butein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signaling.

Authors:  Bokyung Sung; Sung-Gook Cho; Mingyao Liu; Bharat B Aggarwal
Journal:  Int J Cancer       Date:  2011-03-11       Impact factor: 7.396

3.  Transforming growth factor (TGF)-β-activated kinase 1 (TAK1) activation requires phosphorylation of serine 412 by protein kinase A catalytic subunit α (PKACα) and X-linked protein kinase (PRKX).

Authors:  Chuan Ouyang; Li Nie; Meidi Gu; Ailing Wu; Xu Han; Xiaojian Wang; Jianzhong Shao; Zongping Xia
Journal:  J Biol Chem       Date:  2014-07-15       Impact factor: 5.157

4.  Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling.

Authors:  Nicholas Paquette; Joseph Conlon; Charles Sweet; Florentina Rus; Lindsay Wilson; Andrea Pereira; Charles V Rosadini; Nadege Goutagny; Alexander N R Weber; William S Lane; Scott A Shaffer; Stephanie Maniatis; Katherine A Fitzgerald; Lynda Stuart; Neal Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

5.  Potent anti-inflammatory effect of a novel furan-2,5-dione derivative, BPD, mediated by dual suppression of COX-2 activity and LPS-induced inflammatory gene expression via NF-κB inactivation.

Authors:  Ji-Sun Shin; Seung-Jae Park; Suran Ryu; Han Byul Kang; Tae Woo Kim; Jung-Hye Choi; Jae-Yeol Lee; Young-Wuk Cho; Kyung-Tae Lee
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

6.  GSK-3α promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-κB.

Authors:  Deepali Bang; Willie Wilson; Meagan Ryan; Jen Jen Yeh; Albert S Baldwin
Journal:  Cancer Discov       Date:  2013-04-01       Impact factor: 39.397

Review 7.  Toll-like receptor signaling in cell proliferation and survival.

Authors:  Xinyan Li; Song Jiang; Richard I Tapping
Journal:  Cytokine       Date:  2009-09-22       Impact factor: 3.861

8.  Stimulation of NF-κB activity by the HIV restriction factor BST2.

Authors:  Andrey Tokarev; Marissa Suarez; Wilson Kwan; Kathleen Fitzpatrick; Rajendra Singh; John Guatelli
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

9.  LPS-mediated endothelial activation in pulmonary endothelial cells: role of Nox2-dependent IKK-β phosphorylation.

Authors:  Heather Menden; Everett Tate; Neil Hogg; Venkatesh Sampath
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-18       Impact factor: 5.464

10.  Mapping of protein phosphatase-6 association with its SAPS domain regulatory subunit using a model of helical repeats.

Authors:  Julien Guergnon; Urszula Derewenda; Jessica R Edelson; David L Brautigan
Journal:  BMC Biochem       Date:  2009-10-16       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.